Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision changed from v3.3.1 to v3.3.2; no study content or critical elements were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:06:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:03.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The temporary operating-status notice about government funding was removed. Core study information and links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:29:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Outcome Measures section has been expanded to show current and original endpoints (PFS, OS, ORR, Clinical Benefit Rate, Duration of Response) with detailed definitions. This adds more detail on how outcomes are measured and the time frames for analysis.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:26.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Update introduces a government-status notice and a new software version (v3.2.0), replacing the previous v3.1.0 mention.
    Difference
    4%
    Check dated 2025-10-05T10:11:47.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:14:32.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.